David F. McDermott, M.D., is optimistic about combination regimens shaping the treatment landscape for renal cell carcinoma.
Patients in a small study who were placed on a certain diet plan for three months saw a decrease in fatigue from breast cancer treatments.
A recent study found that Opdivo improves survival in patients with gastric or gastroesophageal junction (GEJ) cancer.
A recent study found that there is a period of time by which post-operative chemotherapy can be delayed without having negative impacts for patients with lung cancer.
A recent study found that frequent, moderate exercise may reduce mortality and progression in patients with metastatic colorectal cancer.
Roy Herbst, M.D., Ph.D., spoke with CURE about the future of Keytruda, and immunotherapy in general, to treat lung cancer.
Imbruvica was granted an accelerated FDA approval to treat some patients with marginal zone lymphoma (MZL).
Genetics can help determine a patient's risk of developing a brain tumor, as well as what treatments may work.
A recent study found that there has been a sharp decrease in the percentage of men who are being treated for prostate cancer.